Anthropic Plans to Commit 5% of Shares to Public Benefit Fund Ahead of Potential $1 Trillion IPO
Anthropic, the maker of the Claude AI assistant, announced on Sunday 19 October 2026 that it plans to commit 5% of its shares to a newly created public benefit fund, subject to stockholder approval. The fund would be structured as a wholly owned limited liability company and could receive an additional 2% of Anthropic's shares at the board's discretion for every 50% increase in the company's value above a baseline yet to be disclosed. Taken together with existing share commitments to public purposes, roughly 20% of Anthropic's shares would be dedicated to public benefit goals, excluding any further shares triggered by future valuation milestones. The fund could support nonprofit donations, direct distributions to specific populations, and efforts to address the impact of AI on workers. Anthropic confirmed that none of the equity held by the fund would be used for lobbying or political contributions in the US or abroad. Anthropicis planning what could be one of the largest IPOs (initial public offerings) in history, structured as a public benefit corporation, a legal form that requires management to weigh broader societal interests alongside shareholder returns. Its most recent IPO prospectus reportedly warned that its AI models could exhibit self-preserving behaviours and flagged catastrophic or existential risks to humanity. Last week, Anthropic told prospective investors that its revenue surged 45% to $16.8bn in the three months to the end of September 2026. Elon Musk commented on the announcement on social media, suggesting the shares be given directly to the public.
Why this matters
Anthropic's public benefit fund commitment, made at the eve of what could be a landmark IPO valuation exceeding $1 trillion, is a deliberate reputational and governance move to get ahead of regulatory and public scrutiny of AI companies. Structuring as a public benefit corporation signals to institutional investors and regulators that management will formally weigh societal harms alongside profit, a feature that may become a template for other frontier AI companies navigating hostile legislative environments. The 45% quarterly revenue surge reinforces investor appetite but also raises the stakes on corporate governance scrutiny at listing, as markets will test whether the public benefit obligations are substantive or cosmetic. The timing, shortly after a prospectus acknowledging existential risk, creates a direct legal tension between fiduciary duties to shareholders and the stated public benefit mission that courts may eventually be asked to resolve.
On the Ground
The IPO will generate substantial capital markets work: prospectus drafting and verification, comfort letter coordination, listing application forms, and PDMR (persons discharging managerial responsibilities) notification letters. The public benefit corporation structure adds a layer of bespoke constitutional and governance document drafting not typical of standard US listings. If Anthropic pursues a London or dual listing, English law solicitors would be engaged on verification and cross-border legal opinion coordination. A trainee on this matter would assist with prospectus proofreading and verification notes, cross-referencing every factual claim in the prospectus against underlying source documents, and preparing pricing supplement schedules.
Interview prep
Question you might get
“How does Anthropic's public benefit corporation structure affect the duties owed to shareholders at IPO, and what risks does it create for institutional investors taking a position?”
Sign up free to see the full answer
A model answer you can lift into an interview — how to frame this story for a partner.
Sign up freeSources
My notes
saved